December 2, 2025 03:12 PM EST
PharmaLaw
New York judge revives Bristol Myers dispute over Celgene deal
Nicole DeFeudis
Senior Reporter
A New York federal judge has revived a .7 billion contract dispute related to Bristol Myers Squibb’s 2019 acquisition of Celgene.
US District Judge Jesse …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER